Tezepelumab granted Priority Review by U.S. FDA
The Pharma Data
JULY 8, 2021
“We are proud to advance an innovative, first-in-class monoclonal antibody that targets the top of the inflammatory cascade and represents a potentially transformative treatment option for a broad population of patients with severe asthma. Ann Allergy Asthma Immunol. World Allergy Organization (WAO). EMJ Allergy Immunol.
Let's personalize your content